|
|
|
| Death and life loss due to breast cancer in Wenzhou City |
| YE Zhenmiao, FAN Lihui, ZHENG Yuhang, JIANG Xuexia, LI Huijun, ZHANG Mohan, XIE Yimin, LUO Yongyuan, JIN Xi
|
| Department of Non-communicable Diseases Control and Prevention, Wenzhou Center for Disease Control and Prevention (Wenzhou Institute of Health Inspection), Wenzhou, Zhejiang 325000, China |
|
|
|
|
Abstract Objective To investigate the mortality and life loss of female breast cancer in Wenzhou City, Zhejiang Province from 2014 to 2022, so as to provide the evidence for prevention and control of breast cancer. Methods Data of female breast cancer deaths in Wenzhou City were collected through the Wenzhou Chronic Disease Monitoring and Management information System from 2014 to 2012. The mortality of breast cancer was calculated, and standardized by the data from the Sixth Chinese National Population Census in 2010 (Chinese-standardized rate) and the world standard population first introduced by Segi (world-standardized rate). The life loss were measured using potential years of life lost (PYLL), rate of potential years of life lost (PYLLR) and average years of life lost (AYLL). The trends in mortality, PYLLR and AYLL were analyzed using the average annual percent change (AAPC). Results Totally 2 523 deaths were reported due to breast cancer from 2014 to 2022, ranking fifth in the order of female malignant tumor deaths. The crude mortality of female breast cancer was 7.13/105, showing an increasing trend with AAPC of 2.186% (P<0.05). The Chinese population-standardized mortality and global population-standardized mortality were 5.93/105 and 4.39/105, showing no significant trend with AAPC of -0.617% and -0.602% (both P>0.05), respectively. The crude mortality of female breast cancer appeared a tendency towards a rise with age (P<0.05). The crude mortality of breast cancer in females aged 65 years and older showed an increasing trend (AAPC=3.283%, P<0.05), but there were no significant tendency aged 15 to <45 years and 45 to <65 years (AAPC=-1.011% and -1.850%, both P>0.05). The PYLL, PYLLR and AYLL of breast cancer were 41 227.50 person-years, 1.23‰ and 19.44 years per person, respectively. AYLL showed a decreasing trend (AAPC=-1.969%, P<0.05), and PYLLR showed no significant trend (AAPC=-0.527%, P>0.05). Conclusions The mortality of female breast cancer in Wenzhou City appeared a tendency towards a rise from 2014 to 2022, and AYLL appeared a downward trend. Females aged 65 years and older were the key groups for the prevention and control of breast cancer.
|
|
Received: 26 April 2024
Revised: 27 June 2024
Published: 18 September 2024
|
|
|
|
|
|
[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.
[2] 范文凭,林琳,刘江美,等.基于GBD数据分析1990—2019年中国恶性肿瘤疾病负担趋势[J].中国肿瘤,2024,33(1):20-26.
[3] 蒲星月,马原,钟志刚.2006—2020年中国女性乳腺癌死亡趋势分析——基于年龄-时期-出生队列模型[J].卫生经济研究,2023,40(2):28-33.
[4] 郑荣寿,陈茹,韩冰峰,等.2022年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2024,46(3):221-231.
[5] 程向东,杜灵彬.2022浙江省肿瘤登记年报[R].北京:清华大学出版社,2023.
[6] BRAY F,GUILLOUX A,SANKILA R,et al.Practical implications of imposing a new world standard population[J].Cancer Causes Control,2002,13(2):175-182.
[7] 倪建晓,吴文秀,苏依所,等.2013—2020年瓯海区居民恶性肿瘤死亡趋势及减寿分析[J].预防医学,2022,34(4):413-418.
[8] 马佳鑫,韦再华,苏健婷,等.2010—2020年北京市女性乳腺癌死亡情况及趋势分析[J].疾病监测,2022,37(5):674-678.
[9] 丁晶莹,俞梅华,黃铮.2012—2021年浙江省湖州市女性乳腺癌死亡及寿命损失时间趋势分析[J].疾病监测,2022,37(10):1371-1375.
[10] 崔俊鹏,陆艳,黄春妍,等.2007—2021年苏州市女性乳腺癌死亡与减寿分析[J].预防医学,2023,35(5):380-383.
[11] 王莹,马霞,宫舒萍,等.2011—2021年山东省济南市女性乳腺癌死亡趋势分析[J].中国肿瘤,2023,32(10):766-772.
[12] 张馨,吴羡美,李虹,等.1990—2019年中国女性人群归因于代谢危险因素的乳腺癌疾病负担[J].实用肿瘤学杂志,2023,37(2):107-111.
[13] 胡碧波,傅克本,顾永权.2011—2018年余姚市恶性肿瘤发病趋势[J].预防医学,2023,35(1):44-47,52.
[14] 李增俊,林奕蝶,陈海畅,等.女性雌激素与乳腺癌发病和死亡风险因果关联的孟德尔随机化研究[J].现代预防医学,2024,51(6):1012-1016.
[15] 裘凤黔,杜娟,纪云芳,等.2012—2016年黄浦区恶性肿瘤发病和死亡分析[J].预防医学,2021,33(7):697-700.
[16] 李辉,龚清海,孙校华,等.宁波市城市居民恶性肿瘤风险评估及临床筛查结果分析[J].预防医学,2017,29(10):1024-1026. |
|
|
|
